compound 8ic [PMID: 19081254]   Click here for help

GtoPdb Ligand ID: 9478

Synonyms: CCR4 Antagonist
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This Astellas Pharma compound 8ic is a potent competitive CCR4 antagonist. Oral administration showed anti-inflammatory activity in a murine model of acute dermatitis [1] (n.b. caution, there is no specificity data in this paper). There are some data links for the dichloride (PubChem CID 56972238).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 62.75
Molecular weight 467.33
XLogP 5.73
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES COc1cc2c(NC3CCCCCC3)nc(nc2cc1OC)N1CCC(CC1)N1CCCCC1
Isomeric SMILES COc1cc2c(NC3CCCCCC3)nc(nc2cc1OC)N1CCC(CC1)N1CCCCC1
InChI InChI=1S/C27H41N5O2/c1-33-24-18-22-23(19-25(24)34-2)29-27(30-26(22)28-20-10-6-3-4-7-11-20)32-16-12-21(13-17-32)31-14-8-5-9-15-31/h18-21H,3-17H2,1-2H3,(H,28,29,30)
Bioactivity Comments
CCR4 antagonist activities of the synthesized compounds were determined by measuring the degree to which human CCL22-derived [35S]GTPγS was prevented from binding to the receptor.
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CCR4 Primary target of this compound Hs Antagonist Antagonist 7.7 pIC50 - 1
pIC50 7.7 (IC50 1.8x10-8 M) [1]